Weijie Wang

机构：Shanghai Medical College of Fudan University · ORCID：0009-0004-4320-9119

发表论文 95 篇 · 总被引 2181 次 · h-index 26

代表论文

• Confined Cascade Metabolic Reprogramming Nanoreactor for Targeted Alcohol Detoxification and Alcoholic Liver Injury Management (2023 · ACS Nano · 被引 40)
• Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD (2024 · Cell Reports Medicine · 被引 22)
• Direct infection of SARS-CoV-2 in human iPSC-derived 3D cardiac organoids recapitulates COVID-19 myocarditis (2023 · Virologica Sinica · 被引 16)
• Nrf2 activation by neferine mitigates microglial neuroinflammation after subarachnoid hemorrhage through inhibiting TAK1-NF-κB signaling (2024 · International Immunopharmacology · 被引 12)
• SCR‐7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the S ‐adenosylmethionine‐competitive or the methylthioadenosine‐cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase‐deleted tumors (2024 · MedComm · 被引 10)
• A coumarin-furoxan hybrid as novel nitric oxide donor induced cell apoptosis and ferroptosis in NSCLC by promoting S-nitrosylation of STAT3 and negative regulation of JAK2-STAT3 pathway (2024 · Biochemical Pharmacology · 被引 9)